This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB07785/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07785/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07785/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07785/identifier/chemspider/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07785/identifier/pdb/

Statements

Subject Item
n2:DB07785
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB07785 n13:DB07785
dcterms:title
1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE
adms:identifier
n8:395651 n9:449015 n10:99444256 n11:DB07785 n12:FRC
n5:IUPAC-Name
n6:271B3EEF-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B3EF5-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B3EF4-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B3EF1-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B3EF2-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B3EF3-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B3EED-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B3EEE-363D-11E5-9242-09173F13E4C5 n6:271B3EEB-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B3EEC-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B3EFB-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B3EFC-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B3EF6-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B3EF7-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B3EF9-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B3EF8-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B3EFA-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B3F01-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B3F03-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B3F04-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B3F00-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B3EFF-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B3F02-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B3EF0-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B3EFD-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B3EFE-363D-11E5-9242-09173F13E4C5